Clinical Anesthesia Procedures
- β-Adrenergic Antagonists (Table 18.3)
- Adrenergic Receptors and Their Effect Sites (Table 18.1)
- Adult and Pediatric Cardiopulmonary Resuscitation (Table 39.2)
- Age Dependence of Typical Respiratory Parameters (Table 33.3)
- Alternative CPB Anticoagulation in Patients With HIT (Table 29.4)
- Anticoagulation and Epidural Anesthesia/Analgesia Guidelines (Table 20.3)
- Antiemetic Agents (Table 1.3)
- Antiplatelet Agents (Table 29.3)
- Apgar Scores (Table 33.2)
- Approach to Suspected Acute Hemolytic Transfusion Reaction (Table 36.3)
- ASA Physical Status Classification System (Table 1.1)
- ASA Practice Guidelines for Preoperative Fasting (Table 1.2)
- ASA Practice Guidelines for Preoperative Fasting (Table 11.1)
- Cardiovascular Side Effects of Neuromuscular-Blocking Drugs (Table 14.2)
- Cardiovascular Variables (Table 33.4)
- Cerebral Physiologic Effects of Inhalational Anesthetics (Table 23.1)
- Checklist for Daily Follow-Up of Patients With Perineural Catheters (Table 38.11)
- Classification of Common NSAIDs Based on COX Inhibition and Selectivity (Table 38.1)
- Classification of Nerve Fibers (Table 19.1)
- Classification of Patients With Intracranial Aneurysms According to Surgical Risk (Hunt and Hess Classification) (Table 23.2)
- Classification System for Recommendation and Levels of Evidence (Table 39.1)
- Clinical Assessment of Neuromuscular Blockade (Table 14.3)
- Clinical Diagnosis and Severity Grading Criteria for ARDS (Table 4.2)
- Clinical Uses of Local Anesthetics (Table 19.2)
- Cognitive Error Catalog (Table 9.1)
- Common Intravenous Antibiotics
- Common Oral Opioid and Opioid/Acetaminophen Combinations Used to Treat Mild to Moderate Pain (Table 38.5)
- Comparative Clinical Pharmacology of Neuromuscular-blocking Drugsa (Table 14.1)
- Crisis Resource Management (CRM) Principles (Table 9.2)
- Criteria for Acute Kidney Injury (Table 5.1)
- Direct and Indirect Conditions That Place Patients at Risk of Developing ARDS (Table 4.1)
- Diuretics (Table 5.4)
- Dosages of Commonly Used IV Anesthetics and Induction Dose Onset and Duration (Table 12.1)
- Dose, Time to Peak Effect, and the Duration of Analgesia for Intravenous Opioid Agonists and Agonist-Antagonistsa (Table 12.2)
- Drug Dosages of Commonly Used Vasopressors and Inotropes (Table 18.2)
- Drugs and Dosages (in mg) for Spinal Anesthesia (Table 20.2)
- Factors That Increase the Risk of NSAID-Induced Renal Toxicity (Table 38.3)
- Fasting Guidelines (Table 33.5)
- Glasgow Coma Score (Table 35.1)
- Glucocorticoid and Mineralocorticoid Hormones (Table 7.6)
- Guidelines for Choice of Laryngoscope Blades (Table 33.6)
- Guidelines for Endotracheal Tube Sizes (Table 33.7)
- Guidelines for Opioid Administration in Pediatric Patients (Table 33.8)
- Guidelines for Opioid Administration via IV PCA (Table 38.7)
- Guidelines for Routine Regular IV Insulin Infusion (Table 7.3)
- Hemodynamic Changes and Management After CPB (Table 29.6)
- Hypercalcemia: Signs and Symptoms (Table 7.5)
- Inferior Vena Cava Diameter correlation to Central Venous Pressure (Table 2.2)
- Intraoperative Monitoring Challenges in Patients With Major Burn Injury (Table 35.2)
- Laryngeal Mask Airway Sizesa (Table 13.2)
- Local Anesthetic Agents (Table 19.3)
- Major Blood Vessels at Risk of Injury During Common Surgical Spine Procedures (Table 24.1)
- Management of Flow Through the Atrial-to-Left-Femoral-Artery Bypass Shunt (Table 28.1)
- Managing Patients With Opioid Tolerance or With Current or Previous Dependence (Table 38.12)
- Maximal Flow Rates of Common Venous Access Catheters (Table 40.1)
- MELD Score and MELD-Na (Table 6.2)
- Modified Child-Pugh Score (Table 6.1)
- Muscle Relaxants Used in the Management of Pain Related to Muscular Spasm (Table 38.6)
- National Kidney Foundation Classification of CKD (Table 5.3)
- Noninsulin Agents Used to Treat DM (Table 7.1)
- Normal Intracardiac Pressure and Oxygen Saturation (Table 29.1)
- Normal Vital Signs (Table 33.1)
- Pathological Changes in Donation After Brain Death Donors by Organ System (Table 25.2)
- Perioperative Considerations for the Patient Receiving Long-Term Buprenorphine Treatment (Table 38.13)
- Pharmacologic Considerations for Perioperative Drugs Used in Patients With Chronic Renal Insufficiency (Table 5.5)
- Pharmacologic Management of Common Side Effects Associated With Neuraxial Opioid Administration (Table 38.8)
- Physiologic Changes Associated With Pregnancy (Table 32.1)
- Potential Problems During CPB (Table 29.5)
- Properties of Inhalation Anesthetics (Table 12.3)
- Risk Factors That Increase the Risk of NSAID-Induced GI Toxicity (Table 38.2)
- SCIP-Recommended Perioperative Prophylactic Antibiotics (Table 8.2)
- Selected Nonopioid Analgesics and Comparative Efficiency (Table 38.4)
- Specific Congenital Cardiac Lesions (Table 29.7)
- Spontaneous Abortion Classification (Table 32.2)
- Standard Grading System for Left Ventricle Wall Motion (Table 2.1)
- Subcutaneous Insulin Preparations Used to Treat DM (Table 7.2)
- Suggested Daily Checklist for Daily Management of Patients Receiving Epidural Analgesia (Table 38.10)
- Suggested Management of Inadequate Analgesia in Patients Receiving Continuous Epidural Analgesia (Table 38.9)
- Suggested Minimum Cutaneous Levels for Spinal Anesthesia (Table 20.1)
- Summary of Perioperative Transfusion Considerations (Table 36.1)
- Transfusion Compatibility (Table 36.2)
- Transfusion-Related Infection Risk (Table 8.1)
- Treatment of Thyroid Storm (Table 7.4)
- UNOS Guidelines for Maximum Cold Ischemic Times for Commonly Transplanted Organs (Table 25.1)
- Urine and Serum Diagnostic Indexes (Table 5.2)
- Vasodilator Infusions (Table 18.4)
- Ventricular Function Indices (Table 29.2)
- Wilson Score (Table 13.1)